{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:07:15Z","timestamp":1786997235335,"version":"build-2736575974"},"reference-count":185,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009075","name":"Bankhead-Coley","doi-asserted-by":"publisher","award":["7BC05"],"award-info":[{"award-number":["7BC05"]}],"id":[{"id":"10.13039\/100009075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.survophthal.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T22:49:28Z","timestamp":1545259768000},"page":"272-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Melanoma of the eyelid and periocular skin: Histopathologic classification and molecular pathology"],"prefix":"10.1016","volume":"64","author":[{"given":"Norberto","family":"Mancera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiran S.M.","family":"Smalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis E.","family":"Margo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2018.12.002_bib1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/DAD.0b013e31828a2ec5","article-title":"Cutaneous malignant melanoma: update on diagnostic and prognostic biomarkers","volume":"36","author":"Abbas","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13671-018-0218-9","article-title":"Confocal Microscopy in Skin Cancer","volume":"7","author":"Ahlgrimm-Siess","year":"2018","journal-title":"Curr Dermatol Rep"},{"key":"10.1016\/j.survophthal.2018.12.002_bib3","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.survophthal.2018.12.002_bib4","series-title":"AJCC Cancer Staging Manual","year":"2017"},{"key":"10.1016\/j.survophthal.2018.12.002_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<91::AID-IJC17>3.0.CO;2-K","article-title":"Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type","volume":"79","author":"Akslen","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.0022-202X.2005.23788.x","article-title":"BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival","volume":"125","author":"Akslen","year":"2005","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/308069a0","article-title":"Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?","volume":"308","author":"Albino","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2018.12.002_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.stomax.2008.03.003","article-title":"[Intracranial spread of a melanoma of the face: the trigeminal pathway]","volume":"109","author":"Alix","year":"2008","journal-title":"Rev Stomatol Chir Maxillofac"},{"key":"10.1016\/j.survophthal.2018.12.002_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaad.2016.08.032","article-title":"Correlation between digital epiluminescence microscopy parameters and histopathological changes in lentigo maligna and solar lentigo: A dermoscopic index for the diagnosis of lentigo maligna","volume":"76","author":"Annessi","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib10","series-title":"DIfferential diagnosis in dermatology","author":"Ashton","year":"1990"},{"key":"10.1016\/j.survophthal.2018.12.002_bib11","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/cncr.11196","article-title":"Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center","volume":"97","author":"Azzola","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000658-197812000-00004","article-title":"A\u00a0multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods","volume":"188","author":"Balch","year":"1978","journal-title":"Ann Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","article-title":"Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial","volume":"7","author":"Balch","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib14","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib15","series-title":"Pathology of Malignant Melanoma","author":"Barnhill","year":"2004"},{"key":"10.1016\/j.survophthal.2018.12.002_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1529-8019.2005.00055.x","article-title":"Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool","volume":"19","author":"Bauer","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.survophthal.2018.12.002_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1755-148X.2011.00837.x","article-title":"BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site","volume":"24","author":"Bauer","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib18","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","article-title":"KIT gene mutations and copy number in melanoma subtypes","volume":"14","author":"Beadling","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jnci\/dji019","article-title":"Sun exposure and mortality from melanoma","volume":"97","author":"Berwick","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.survophthal.2018.12.002_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1523-1747.2000.00877.x","article-title":"Mutation and allelic loss of the PTEN\/MMAC1 gene in primary and metastatic melanoma biopsies","volume":"114","author":"Birck","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2559.1999.00672.x","article-title":"Benign atypical naevi: diagnostic difficulties and continued controversy","volume":"34","author":"Blessing","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08820530500353864","article-title":"Cutaneous melanomas of the eyelid","volume":"21","author":"Boulos","year":"2006","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","article-title":"Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma","volume":"172","author":"Breslow","year":"1970","journal-title":"Ann Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00000658-197511000-00007","article-title":"Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma","volume":"182","author":"Breslow","year":"1975","journal-title":"Ann Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0046-8177(77)80061-0","article-title":"Problems in the measurement of tumor thickness and level of invasion in cutaneous melanoma","volume":"8","author":"Breslow","year":"1977","journal-title":"Hum Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1755-148X.2010.00778.x","article-title":"Genetic and morphologic features for melanoma classification","volume":"23","author":"Broekaert","year":"2010","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib27","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8","article-title":"Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification","volume":"75","author":"Buttner","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1200\/JCO.1997.15.3.1039","article-title":"Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system","volume":"15","author":"Buzaid","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jaad.2004.08.034","article-title":"Molecular diagnostics in melanoma","volume":"52","author":"Carlson","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib30","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/cup.12751","article-title":"Achieving consensus for the histopathologic diagnosis of melanocytic lesions: use of the modified Delphi method","volume":"43","author":"Carney","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ophtha.2006.08.043","article-title":"Treatment and outcomes of malignant melanoma of the eyelid: a review of 29 cases in Australia","volume":"114","author":"Chan","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.suc.2014.07.011","article-title":"Head and neck melanoma","volume":"94","author":"Cheriyan","year":"2014","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.survophthal.2018.12.002_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.MP.0000072747.08404.38","article-title":"Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions","volume":"16","author":"Chorny","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib34","series-title":"A\u00a0classification of malignant melanoma in man correlated with histogenesis and biologic behavior","author":"Clark","year":"1967"},{"key":"10.1016\/j.survophthal.2018.12.002_bib35","first-page":"705","article-title":"The histogenesis and biologic behavior of primary human malignant melanomas of the skin","volume":"29","author":"Clark","year":"1969","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0046-8177(86)80032-6","article-title":"The biologic forms of malignant melanoma","volume":"17","author":"Clark","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib37","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"Clark","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.survophthal.2018.12.002_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/cup.12475","article-title":"Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma","volume":"42","author":"Clarke","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2559.1996.d01-464.x","article-title":"The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel","volume":"28","author":"Cook","year":"1996","journal-title":"Histopathology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib40","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1996.14.4.1218","article-title":"Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions","volume":"14","author":"Corona","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib41","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib42","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","article-title":"Somatic activation of KIT in distinct subtypes of melanoma","volume":"24","author":"Curtin","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib43","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","article-title":"Braf(V600E) cooperates with Pten loss to induce metastatic melanoma","volume":"41","author":"Dankort","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.survophthal.2018.12.002_bib44","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2018.12.002_bib45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000079490","article-title":"B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome","volume":"66","author":"Deichmann","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib46","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.ophtha.2008.06.011","article-title":"Management of periocular cutaneous melanoma with a staged excision technique and permanent sections the square procedure","volume":"115","author":"Demirci","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00002341-199903000-00013","article-title":"Desmoplastic spindle-cell melanoma of the eyelid with orbital invasion","volume":"15","author":"Dithmar","year":"1999","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib49","doi-asserted-by":"crossref","first-page":"318s","DOI":"10.1038\/jid.1993.55","article-title":"Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study","volume":"100","author":"Duncan","year":"1993","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib50","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0190-9622(92)70248-E","article-title":"An analysis of interobserver recognition of the histopathologic features of dysplastic nevi from a mixed group of nevomelanocytic lesions","volume":"27","author":"Duray","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing","volume":"16","author":"Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2018.02.070","article-title":"Pathologist Characteristics Associated with Accuracy and Reproducibility of Melanocytic Skin Lesion Interpretation","volume":"79","author":"Elder","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1158\/1078-0432.CCR-10-2276","article-title":"Clinical correlates of NRAS and BRAF mutations in primary human melanoma","volume":"17","author":"Ellerhorst","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib54","doi-asserted-by":"crossref","first-page":"j2813","DOI":"10.1136\/bmj.j2813","article-title":"Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study","volume":"357","author":"Elmore","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.survophthal.2018.12.002_bib55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.IOP.0000056141.97930.E8","article-title":"Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report","volume":"19","author":"Esmaeli","year":"2003","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib56","first-page":"338","article-title":"Enhanced melanoma diagnosis with multispectral digital skin lesion analysis","volume":"101","author":"Farberg","year":"2018","journal-title":"Cutis"},{"key":"10.1016\/j.survophthal.2018.12.002_bib57","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0046-8177(96)90157-4","article-title":"Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists","volume":"27","author":"Farmer","year":"1996","journal-title":"Hum Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bcp.2011.05.015","article-title":"Acquired and intrinsic BRAF inhibitor resistance in BRAF V600E mutant melanoma","volume":"82","author":"Fedorenko","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib59","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/CMR.0000000000000478","article-title":"Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions","volume":"28","author":"Ferris","year":"2018","journal-title":"Melanoma Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib60","series-title":"Color atlas and synopsis of clinical dermatology","author":"Fitzpatrick","year":"1992"},{"key":"10.1016\/j.survophthal.2018.12.002_bib61","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1245\/ASO.2004.07.014","article-title":"The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up","volume":"11","author":"Francken","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31822d5ff8","article-title":"Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe","volume":"36","author":"Gammon","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejca.2004.10.016","article-title":"Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2018.12.002_bib65","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic Classification of Cutaneous Melanoma","volume":"161","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2018.12.002_bib66","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":"Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib67","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jmoldx.2011.01.011","article-title":"Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma","volume":"13","author":"Gerami","year":"2011","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.survophthal.2018.12.002_bib68","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PAS.0b013e31824b1efd","article-title":"A\u00a0highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms","volume":"36","author":"Gerami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib69","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0b013e3182753de6","article-title":"Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations","volume":"37","author":"Gerami","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jaad.2014.04.042","article-title":"Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin","volume":"71","author":"Gerami","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib71","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/PAS.0000000000000198","article-title":"Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up","volume":"38","author":"Gerami","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jaad.2016.07.038","article-title":"Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma","volume":"76","author":"Gerami","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib73","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1245\/s10434-010-0986-3","article-title":"2010 TNM staging system for cutaneous melanoma\u2026and beyond","volume":"17","author":"Gershenwald","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib74","first-page":"472","article-title":"Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.survophthal.2018.12.002_bib75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006534-199807000-00003","article-title":"Periorbital melanocytic lesions: excision and reconstruction in 40 patients","volume":"102","author":"Glat","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib76","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archotol.133.5.442","article-title":"Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study","volume":"133","author":"Golger","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib77","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djp038","article-title":"Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis","volume":"101","author":"Gould Rothberg","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.survophthal.2018.12.002_bib78","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/his.12993","article-title":"Digital pathology in clinical use: where are we now and what is holding us back?","volume":"70","author":"Griffin","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib79","first-page":"1867","article-title":"Cutaneous melanoma of the eyelid","volume":"98","author":"Grossniklaus","year":"1991","journal-title":"Clinicopathologic Features Ophthalmol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib80","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bjps.2013.04.032","article-title":"Margins of excision and prognostic factors for cutaneous eyelid melanomas","volume":"66","author":"Harish","year":"2013","journal-title":"J\u00a0Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib81","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2559.1984.tb02388.x","article-title":"Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia","volume":"8","author":"Heenan","year":"1984","journal-title":"Histopathology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib82","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2016.06.048","article-title":"Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location","volume":"75","author":"Helsing","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2015.04.014","article-title":"Melanoma in situ: Part I. Epidemiology, screening, and clinical features","volume":"73","author":"Higgins","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A\u00a0Landscape of Driver Mutations in Melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2018.12.002_bib85","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamadermatol.2018.1764","article-title":"Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions","volume":"154","author":"Hornberger","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib86","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/archdermatol.2009.302","article-title":"Disparity in melanoma: a trend analysis of melanoma incidence and stage at diagnosis among whites, Hispanics, and blacks in Florida","volume":"145","author":"Hu","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib87","series-title":"Human malignant melanoma","year":"1979"},{"key":"10.1016\/j.survophthal.2018.12.002_bib88","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib89","first-page":"917","article-title":"Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas","volume":"10","author":"Kanter-Lewensohn","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib90","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/107327481602300205","article-title":"Management of primary acquired melanosis, nevus, and conjunctival melanoma","volume":"23","author":"Kao","year":"2016","journal-title":"Cancer Control"},{"key":"10.1016\/j.survophthal.2018.12.002_bib91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5858\/2009-0538-RA.1","article-title":"Lentiginous melanoma","volume":"135","author":"King","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib92","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/labinvest.2016.142","article-title":"The NF1 gene in tumor syndromes and melanoma","volume":"97","author":"Kiuru","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.survophthal.2018.12.002_bib93","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/cas.13342","article-title":"Long non-coding RNAs as an epigenetic regulator in human cancers","volume":"108","author":"Kondo","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.survophthal.2018.12.002_bib94","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.5858\/2009-0418-RAR.1","article-title":"Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells","volume":"134","author":"Kong","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib95","series-title":"The skin and eye","author":"Korting","year":"1973"},{"key":"10.1016\/j.survophthal.2018.12.002_bib96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1440-0960.2002.t01-1-00568.x","article-title":"Atypical lentiginous junctional naevi of the elderly and melanoma","volume":"43","author":"Kossard","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib97","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.5694\/j.1326-5377.1956.tb36084.x","article-title":"Some geographical aspects of the mortality from melanoma in Europeans","volume":"43","author":"Lancaster","year":"1956","journal-title":"Med J Aust"},{"key":"10.1016\/j.survophthal.2018.12.002_bib98","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib99","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00000372-200012000-00002","article-title":"A\u00a0zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions","volume":"22","author":"Li","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/ajd.12121","article-title":"Diagnostic accuracy of malignant melanoma according to subtype","volume":"55","author":"Lin","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib101","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.det.2012.04.001","article-title":"Update on the current state of melanoma incidence","volume":"30","author":"Little","year":"2012","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2018.12.002_bib102","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/sj.jid.5700632","article-title":"Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma","volume":"127","author":"Liu","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib103","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2010.32.4327","article-title":"Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma","volume":"29","author":"Long","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib104","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jaad.2016.04.052","article-title":"Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group","volume":"75","author":"Lott","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib105","doi-asserted-by":"crossref","first-page":"e35309","DOI":"10.1371\/journal.pone.0035309","article-title":"Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials","volume":"7","author":"Lovly","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2018.12.002_bib106","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1158\/2159-8290.CD-12-0313","article-title":"Elucidating distinct roles for NF1 in melanomagenesis","volume":"3","author":"Maertens","year":"2013","journal-title":"Cancer Discovery"},{"key":"10.1016\/j.survophthal.2018.12.002_bib107","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/jnci\/djg123","article-title":"Determinants of BRAF mutations in primary melanomas","volume":"95","author":"Maldonado","year":"2003","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.survophthal.2018.12.002_bib108","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0161-6420(03)00670-5","article-title":"Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma","volume":"110","author":"Malhotra","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib109","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00000372-200206000-00016","article-title":"Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness","volume":"24","author":"Mangini","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/archopht.116.2.195","article-title":"Malignant tumors of the eyelid: a population-based study of non-basal cell and non-squamous cell malignant neoplasms","volume":"116","author":"Margo","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib111","first-page":"3430","article-title":"Pigmented lesions of the eyelid","volume":"Vol. 4","author":"Margo","year":"2000"},{"key":"10.1016\/j.survophthal.2018.12.002_bib112","series-title":"Tumors of the Ocular Adnexa. A Histopathologic Primer. Focal Points XXXVI","author":"Margo","year":"2018"},{"key":"10.1016\/j.survophthal.2018.12.002_bib113","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/00313027009077330","article-title":"The classification of melanoma and its relationship with prognosis","volume":"2","author":"McGovern","year":"1970","journal-title":"Pathology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib114","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/1097-0142(197312)32:6<1446::AID-CNCR2820320623>3.0.CO;2-8","article-title":"The classification of malignant melanoma and its histologic reporting","volume":"32","author":"McGovern","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib115","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/00313028609090822","article-title":"The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 Sydney classification","volume":"18","author":"McGovern","year":"1986","journal-title":"Pathology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib116","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2018.12.002_bib117","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJM197105132841907","article-title":"The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas","volume":"284","author":"Mihm","year":"1971","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib118","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1158\/0008-5472.CAN-06-0384","article-title":"Epigenetic silencing of the PTEN gene in melanoma","volume":"66","author":"Mirmohammadsadegh","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib119","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1038\/onc.2009.521","article-title":"Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation","volume":"29","author":"Mishra","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.survophthal.2018.12.002_bib120","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/srt.12008","article-title":"Electrical impedance spectroscopy as a potential adjunct diagnostic tool for cutaneous melanoma","volume":"19","author":"Mohr","year":"2013","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib121","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1002\/1097-0142(19930601)71:11<3737::AID-CNCR2820711143>3.0.CO;2-7","article-title":"Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness","volume":"71","author":"Morton","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib122","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/RLU.0b013e31816a788b","article-title":"Desmoplastic neurotropic melanoma in a patient with trigeminal neuralgia: FDG PET\/CT and MRI","volume":"33","author":"Moulin-Romsee","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib123","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/SLA.0b013e31819ed973","article-title":"Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma","volume":"249","author":"Murali","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib124","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00008390-200506000-00005","article-title":"Prognostic factors in localized invasive cutaneous melanoma: high value of mitotic rate, vascular invasion and microscopic satellitosis","volume":"15","author":"Nagore","year":"2005","journal-title":"Melanoma Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib125","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/DAD.0b013e3181624054","article-title":"Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions","volume":"30","author":"Nasr","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00000372-199302000-00006","article-title":"National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992","volume":"15","year":"1993","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib127","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/jcp.50.3.202","article-title":"A\u00a0nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology. CRC Melanoma Pathology Panel","volume":"50","year":"1997","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib128","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"Nazarian","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2018.12.002_bib129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":"Immunohistochemical characteristics of melanoma","volume":"35","author":"Ohsie","year":"2008","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib130","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/jamadermatol.2018.2388","article-title":"Accuracy of digital pathologic analysis vs traditional microscopy in the interpretation of melanocytic lesions","volume":"154","author":"Onega","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib131","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jdv.14782","article-title":"The limitations of dermoscopy: false-positive and false-negative tumours","volume":"32","author":"Papageorgiou","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib132","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/hed.23801","article-title":"Lymphatic and blood vasculature in primary cutaneous melanomas of the scalp and neck","volume":"37","author":"Pasquali","year":"2015","journal-title":"Head Neck"},{"key":"10.1016\/j.survophthal.2018.12.002_bib133","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaad.2015.09.008","article-title":"Discordance of histopathologic parameters in cutaneous melanoma: Clinical implications","volume":"74","author":"Patrawala","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib134","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cub.2005.01.031","article-title":"BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma","volume":"15","author":"Patton","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib135","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaad.2013.07.027","article-title":"The MPATH-Dx reporting schema for melanocytic proliferations and melanoma","volume":"70","author":"Piepkorn","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib136","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","article-title":"Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","journal-title":"Mol Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib137","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1054","article-title":"High frequency of BRAF mutations in nevi","volume":"33","author":"Pollock","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.survophthal.2018.12.002_bib138","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ijc.2910260206","article-title":"Difficulties encountered in the application of Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma","volume":"26","author":"Prade","year":"1980","journal-title":"Int J Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib139","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1071\/HC10268","article-title":"Digital monitoring by whole body photography and sequential digital dermoscopy detects thinner melanomas","volume":"2","author":"Rademaker","year":"2010","journal-title":"J\u00a0Prim Health Care"},{"key":"10.1016\/j.survophthal.2018.12.002_bib140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/bjc.2016.195","article-title":"Molecular characterisation of cutaneous melanoma: creating a framework for targeted and immune therapies","volume":"115","author":"Rajkumar","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib141","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.2196\/jmir.9392","article-title":"Use of Smartphones for Early Detection of Melanoma: Systematic Review","volume":"20","author":"Rat","year":"2018","journal-title":"J\u00a0Med Internet Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib142","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/bjo.70.12.907","article-title":"Desmoplastic malignant melanoma masquerading as chalazion","volume":"70","author":"Roper","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib143","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.survophthal.2014.08.001","article-title":"Desmoplastic melanoma of the eyelid and conjunctival melanoma in neurofibromatosis type 1: a clinical pathological correlation","volume":"60","author":"Rubinstein","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib144","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/IIO.0b013e3181b7eea7","article-title":"Eyelid and periorbital cutaneous malignant melanoma","volume":"49","author":"Sanchez","year":"2009","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.survophthal.2018.12.002_bib145","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jso.20083","article-title":"Pathology of melanocytic lesions: new, controversial, and clinically important issues","volume":"86","author":"Scolyer","year":"2004","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib146","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molonc.2011.03.002","article-title":"Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care","volume":"5","author":"Scolyer","year":"2011","journal-title":"Mol Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib147","first-page":"64","article-title":"Role of In\u00a0Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions","volume":"26","author":"Serban","year":"2018","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.survophthal.2018.12.002_bib148","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The Genetic Evolution of Melanoma from Precursor Lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib149","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1158\/1078-0432.CCR-1169-3","article-title":"Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas","volume":"10","author":"Shinozaki","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib150","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2009.09.043","article-title":"Discordance in the histopathologic diagnosis of melanoma at a melanoma referral center","volume":"62","author":"Shoo","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib151","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1524-4725.2009.01222.x","article-title":"Modified Mohs micrographic surgery for periocular melanoma and melanoma in situ: long-term experience at Scripps Clinic","volume":"35","author":"Shumaker","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib152","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/PAP.0b013e3182976c94","article-title":"Ras, Raf, and MAP kinase in melanoma","volume":"20","author":"Solus","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib153","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1245\/s10434-010-1050-z","article-title":"Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database","volume":"17","author":"Soong","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib154","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1158\/0008-5472.CAN-04-1399","article-title":"Deregulated Akt3 activity promotes development of malignant melanoma","volume":"64","author":"Stahl","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib155","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00128071-200506030-00002","article-title":"Lentigo maligna : prognosis and treatment options","volume":"6","author":"Stevenson","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib156","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/modpathol.2011.182","article-title":"Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma","volume":"25","author":"Storr","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib157","first-page":"141","article-title":"Desmoplastic malignant melanoma of the upper eyelid","volume":"14","author":"Sutula","year":"1982","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib158","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0190-9622(92)70148-9","article-title":"Malignant melanoma of the eyelid. A report of eight cases and a review of the literature","volume":"27","author":"Tahery","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib159","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/IOP.0000000000001015","article-title":"Desmoplastic Melanoma of the Periorbital Region","volume":"34","author":"Thakar","year":"2018","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib160","first-page":"17","article-title":"Early cure rates with narrow-margin slow-Mohs surgery for periocular malignant melanoma","volume":"35","author":"Then","year":"2009","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.survophthal.2018.12.002_bib161","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(09)61397-0","article-title":"Cutaneous melanoma in the era of molecular profiling","volume":"374","author":"Thompson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2018.12.002_bib162","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1200\/JCO.2010.31.5812","article-title":"Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database","volume":"29","author":"Thompson","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib163","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.0022-202X.2004.22243.x","article-title":"Genetic interaction between NRAS and BRAF mutations and PTEN\/MMAC1 inactivation in melanoma","volume":"122","author":"Tsao","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib164","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hed.23079","article-title":"Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases","volume":"35","author":"Turri-Zanoni","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.survophthal.2018.12.002_bib165","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0161-6420(02)00962-4","article-title":"Clinicopathologic features and behavior of cutaneous eyelid melanoma","volume":"109","author":"Vaziri","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2018.12.002_bib166","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1371\/journal.pmed.0050120","article-title":"Improving melanoma classification by integrating genetic and morphologic features","volume":"5","author":"Viros","year":"2008","journal-title":"Plos Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib167","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2016.06.001","article-title":"Advances in the management of conjunctival melanoma","volume":"62","author":"Vora","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib168","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1101\/gad.187252.112","article-title":"Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis","volume":"26","author":"Vredeveld","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.survophthal.2018.12.002_bib169","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2011.10239.x","article-title":"Noninvasive genomic detection of melanoma","volume":"164","author":"Wachsman","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib170","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1097-0142(196805)21:5<893::AID-CNCR2820210513>3.0.CO;2-8","article-title":"Melanotic freckle of Hutchinson","volume":"21","author":"Wayte","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2018.12.002_bib171","series-title":"Weedon's Skin Pathology","author":"Weedon","year":"2010"},{"key":"10.1016\/j.survophthal.2018.12.002_bib172","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2133.1987.tb05843.x","article-title":"The risk of progression of lentigo maligna to lentigo maligna melanoma","volume":"116","author":"Weinstock","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib173","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/pcmr.12370","article-title":"Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy","volume":"28","author":"Wellbrock","year":"2015","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib174","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1755-148X.2011.00880.x","article-title":"The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin","volume":"24","author":"Whiteman","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.survophthal.2018.12.002_bib175","series-title":"WHO classification of tumours. pathology and genetics of skin tumours","year":"2006"},{"key":"10.1016\/j.survophthal.2018.12.002_bib176","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1038\/sj.onc.1206443","article-title":"Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival","volume":"22","author":"Widlund","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.survophthal.2018.12.002_bib177","first-page":"21","article-title":"Impact of guidance provided by a multispectral digital skin lesion analysis device following dermoscopy on decisions to biopsy atypical melanocytic lesions","volume":"8","author":"Winkelmann","year":"2015","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib178","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1158\/1535-7163.MCT-13-0804","article-title":"A\u00a0Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance","volume":"13","author":"Xia","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.survophthal.2018.12.002_bib179","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/bjophthalmol-2014-305140","article-title":"Number of excisions required to obtain clear surgical margins and prognostic value of AJCC T category for patients with eyelid melanoma","volume":"98","author":"Yin","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib180","series-title":"Staging for patients with Ocular, Orbital and Ocular Adnexal Malignancies. Focal Points XXXIV","author":"Yin","year":"2016"},{"key":"10.1016\/j.survophthal.2018.12.002_bib181","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.2353\/ajpath.2009.081057","article-title":"The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes","volume":"174","author":"Yu","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib182","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clindermatol.2013.05.029","article-title":"Flat pigmented macules on sun-damaged skin of the head\/neck: junctional nevus, atypical lentiginous nevus, or melanoma in situ?","volume":"32","author":"Zalaudek","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.survophthal.2018.12.002_bib183","doi-asserted-by":"crossref","first-page":"300","DOI":"10.5858\/2010-0146-RA.1","article-title":"Nevus\/Melanocytoma\/Melanoma: an emerging paradigm for classification of melanocytic neoplasms?","volume":"135","author":"Zembowicz","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib184","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.5858\/arpa.2011-0673-OA","article-title":"Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions","volume":"136","author":"Zembowicz","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.survophthal.2018.12.002_bib186","doi-asserted-by":"crossref","first-page":"AB212","DOI":"10.1016\/j.jaad.2017.04.826","article-title":"Quantitative ABCD parameters measured by a multispectral digital skin lesion analysis device for evaluation of suspicious pigmented lesions strongly correlate with clinical ABCD observations","volume":"76","author":"Glazer","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962571830211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962571830211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:48:34Z","timestamp":1758541714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003962571830211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":185,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S003962571830211X"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2018.12.002","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melanoma of the eyelid and periocular skin: Histopathologic classification and molecular pathology","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}